Skip to main content

Table 3 Distribution of the FOXP3 alleles and genotypes in schizophrenia patients and healthy controls

From: Analysis of selected polymorphisms in FOXP3 gene in a cohort of Egyptian patients with schizophrenia

Gender

Foxp3 polymorphism

Case (N = 125)

N (%)

Control (N = 160)

N (%)

OR (95% CI)

P-value

Female

rs3761548 (C/A)

AA

3 (4.2)

5 (5.4)

0.77 (0.18–3.36)

0.73*

AC

22 (31.0)

33 (35.5)

0.82 (0.42–1.58)

0.55

CC

46 (64.8)

55 (59.1)

1.27 (0.67–2.41)

0.46

A

28 (19.7)

43 (23.1)

0.82 (0.48–1.39)

0.46

C

114 (80.3)

143 (76.9)

1.22 (0.72–2.09)

0.46

 

HWE

0.80

0.77

  

Male

A

8 (14.8)

6 (9.0)

1.77 (0.57–5.45)

0.32

C

46 (85.2)

61 (91.0)

0.57 (0.18–1.74)

0.32

Female

rs3761549 (C/T)

TT

2 (2.8)

2 (2.2)

1.31 (0.18–9.59)

0.78*

CT

29 (40.8)

38 (40.9)

0.99 (0.53–1.87)

1.00

CC

40 (56.3)

53 (57.0)

0.97 (0.52–1.82)

0.93

T

33 (23.2)

42 (22.6)

1.04 (0.62–1.75)

0.89

C

109 (76.8)

144 (77.4)

0.96 (0.57–1.62)

0.89

 

HWE

0.77

0.77

  

Male

T

18 (33.3)

12 (17.9)

2.29 (0.98–5.32)

0.054

C

36 (66.7)

55 (82.1)

0.44 (0.19–1.01)

0.054

Female

rs2232365 (A/G)

AA

7 (9.9)

10 (10.8)

1.02 (0.37–2.81)

0.97

AG

31 (43.7)

46 (49.5)

0.79 (0.42–1.47)

0.46

GG

33 (46.5)

37 (39.8)

1.10 (0.58–2.08)

0.76

A

45 (31.6)

66 (35.5)

0.84 (0.53–1.34)

0.47

G

97 (68.3)

120 (64.5)

1.18 (0.75–1.89)

0.47

 

HWE

0.68

0.65

  

Male

A

24 (44.4)

32 (47.8)

0.88 (0.43–1.79)

0.72

G

30 (55.6)

35 (52.2)

1.14 (0.57–2.35)

0.72

  1. OR odds ratio, 95% CI 95% confidence interval, HWE Hardy–Weinberg equilibrium
  2. *Fisher’s exact